Copyright ©The Author(s) 2020.
Artif Intell Gastroenterol. Jul 28, 2020; 1(1): 5-11
Published online Jul 28, 2020. doi: 10.35712/aig.v1.i1.5
Table 1 Clinical applications of artificial intelligence
SamplesDiagnosisAI techniqueAccuracy, %AUROCRef.
Focal liver disease detectionUSBenign tumorsDL97.2NA[23]
Serum tests, clinical dataHCCML (gradient boosting)/DL87.34/83.540.940/0.884[25]
Diffuse liver disease stagingUSFLDDL/SVM/ELM100/82/921.0/0.79/0.92[26]
Risk assessmentClinical, pathohistological dataPoorer survival after HCC resection2 DL modelsNA0.78, 0.75 (c-index)[35]
Sequence dataPoorer survival after HCC resectionDLNA0.68 (c-index)[36]
Clinical dataHCC developmentMLNA0.64 (c-index)[37]
Clinical, histological data1-yr and 3-yr clinical outcomesMLNA0.78, 0.76[38]